NVIV Historical PE Ratio image   This NVIV PE ratio history page last updated 6/30/2022
NVIV PE History Chart
PeriodPriceEarningsTTMPE
Q1 2022
5/10/2022
4.13-1.94-7.69NA
Q4 2021
3/7/2022
7.25-2.25-7.75NA
Q3 2021
11/10/2021
13.50-1.7511.751.1
Q2 2021
8/13/2021
15.00-1.751.758.6
Q1 2021
5/10/2021
16.75-2.00-8.75NA
Q4 2020
3/1/2021
30.5017.25-68.50NA
Q3 2020
11/6/2020
13.25-11.75-94.75NA
Q2 2020
8/11/2020
39.25-12.25-300.50NA
Q1 2020
5/13/2020
34.00-61.75-543.25NA
Q4 2019
2/20/2020
176.75-9.00-691.50NA
Q3 2019
11/7/2019
337.50-217.50157.502.1
Q2 2019
8/13/2019
472.50-255.0060.007.9
Q1 2019
5/10/2019
960.00-210.00-907.50NA
Q4 2018
4/1/2019
1147.50840.00-3202.50NA
Q3 2018
11/8/2018
1567.50-315.00-6480.00NA
Q2 2018
8/7/2018
1560.00-1222.50-9727.50NA
Q1 2018
5/7/2018
6225.00-2505.00-12630.00NA
Q4 2017
3/12/2018
12562.50-2437.50-14062.50NA
Q3 2017
10/30/2017
27187.50-3562.50-15562.50NA
Q2 2017
8/8/2017
33750.00-4125.00-15375.00NA
Q1 2017
5/4/2017
63750.00-3937.50-14625.00NA
Q4 2016
3/10/2017
75000.00-3937.50NANA
Q3 2016
11/4/2016
75937.50-3375.00NANA
Q2 2016
8/4/2016
119625.00-3375.00NANA
NVIV Historical PE Ratio Chart
PeriodPriceEarningsAnnualizedPE
Q1 2022
5/10/2022
4.13-1.94-7.76NA
Q4 2021
3/7/2022
7.25-2.25-9.00NA
Q3 2021
11/10/2021
13.50-1.75-7.00NA
Q2 2021
8/13/2021
15.00-1.75-7.00NA
Q1 2021
5/10/2021
16.75-2.00-8.00NA
Q4 2020
3/1/2021
30.5017.2569.000.4
Q3 2020
11/6/2020
13.25-11.75-47.00NA
Q2 2020
8/11/2020
39.25-12.25-49.00NA
Q1 2020
5/13/2020
34.00-61.75-247.00NA
Q4 2019
2/20/2020
176.75-9.00-36.00NA
Q3 2019
11/7/2019
337.50-217.50-870.00NA
Q2 2019
8/13/2019
472.50-255.00-1020.00NA
Q1 2019
5/10/2019
960.00-210.00-840.00NA
Q4 2018
4/1/2019
1147.50840.003360.000.3
Q3 2018
11/8/2018
1567.50-315.00-1260.00NA
Q2 2018
8/7/2018
1560.00-1222.50-4890.00NA
Q1 2018
5/7/2018
6225.00-2505.00-10020.00NA
Q4 2017
3/12/2018
12562.50-2437.50-9750.00NA
Q3 2017
10/30/2017
27187.50-3562.50-14250.00NA
Q2 2017
8/8/2017
33750.00-4125.00-16500.00NA
Q1 2017
5/4/2017
63750.00-3937.50-15750.00NA
Q4 2016
3/10/2017
75000.00-3937.50-15750.00NA
Q3 2016
11/4/2016
75937.50-3375.00-13500.00NA
Q2 2016
8/4/2016
119625.00-3375.00-13500.00NA
Quotes delayed 20 minutes

Email EnvelopeFree NVIV Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
InVivo Therapeutics Hldg (NVIV) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

NVNO PE Ratio History
NVOS PE Ratio History
NVRO PE Ratio History
NVST PE Ratio History
NVTA PE Ratio History
NXTC PE Ratio History
OCGN PE Ratio History
OCUL PE Ratio History
OCUP PE Ratio History
OCX PE Ratio History
On this page we presented the NVIV PE Ratio History information for InVivo Therapeutics Hldg' stock. The average NVIV PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 0.3. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average NVIV PE ratio history based on this TTM earnings result method is 4.9. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this NVIV PE ratio history result, against the recent PE: when this page was posted on 6/29/2022, the most recent closing price for NVIV had been 4.11, and the most recent quarterly earnings result, annualized, was 69. Meanwhile, the most recent TTM earnings summed to 11.75. From these numbers, we calculate the recent NVIV PE on 6/29/2022 based on annualized quarterly EPS was 0.1. Based on NVIV's history, that recent PE is low relative to the historical average, with the recent PE 66.7% lower than the historical average PE across our data set for InVivo Therapeutics Hldg. Looking at the recent NVIV PE on 6/29/2022 based on TTM EPS, we calculate the ratio at 0.3. Based on NVIV's history, that recent PE is low relative to the historical average, with the recent PE 93.9% lower than the average PE across our InVivo Therapeutics Hldg data set with TTM EPS used in the calculation at each period.

For self directed investors doing their due diligence on NVIV or any other given stock, valuation analysis for NVIV can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios justify the current stock market value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate InVivo Therapeutics Hldg PE ratio history — or the PE history for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for next earnings dates and also historical earnings surprises history for NVIV. Thanks for visiting, and the next time you need to research NVIV PE Ratio History or the PE ratio history for another stock, we hope our site will come to mind as your go-to PE ratio history research resource of choice.

Recommended: CCD YTD Return, ETFs Holding JOB, WPCA market cap history.

 

NVIV PE Ratio History | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.